RGLS

Regulus Therapeutics
RGLS

Overview Fund Activity
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

27 hedge funds and large institutions have $2.44M invested in Regulus Therapeutics in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 14 closing their positions.

Holders
27
Holders Change
-9
Holders Change %
-25%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
6
Closed
14
Calls
$5K
Puts
$4K
Net Calls
+$1K
Net Calls Change
+$1K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$149K
2
Bank of New York Mellon
2
Bank of New York Mellon
New York
$25K
3
Two Sigma Investments
3
Two Sigma Investments
New York
$21K
4
WS
4
Wedbush Securities
California
$30K
5
PAM
5
Panagora Asset Management
Massachusetts
$21K

Top Sellers

1
BC
1
Boxer Capital
California
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$0
3
RPAM
3
Rhenman & Partners Asset Management
Sweden
$0
4
BI
4
BVF Inc
California
$979K
5
SDIC
5
South Dakota Investment Council
South Dakota
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
– -$58K -2,439 Closed
USAA
27
United Services Automobile Association
Texas
– -$7K -277 Closed
State Street
28
State Street
Massachusetts
– -$5K -200 Closed
Invesco
29
Invesco
Georgia
– -$4K -150 Closed
TSS
30
Two Sigma Securities
New York
– -$3K -146 Closed
Mariner
31
Mariner
Kansas
– -$3K -130 Closed
BAS
32
Brown Advisory Securities
Maryland
– -$3K -125 Closed
DY
33
Dowling & Yahnke
California
– -$2K -100 Closed
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
– -$1 – –
1
2